161 related articles for article (PubMed ID: 27133674)
21. Assessment of bone marrow involvement by magnetic resonance imaging in small cell lung cancer. No significant change of staging.
Milleron BJ; Le Breton C; Carette MF; Cadranel JL; Akoun GM
Chest; 1994 Oct; 106(4):1030-5. PubMed ID: 7924470
[TBL] [Abstract][Full Text] [Related]
22. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy ((1)H-MRS) at the spine but not the femur.
Cohen A; Shen W; Dempster DW; Zhou H; Recker RR; Lappe JM; Kepley A; Kamanda-Kosseh M; Bucovsky M; Stein EM; Nickolas TL; Shane E
Osteoporos Int; 2015 Oct; 26(10):2471-8. PubMed ID: 25986383
[TBL] [Abstract][Full Text] [Related]
23. Breath-hold MR measurements of fat fraction, T1 , and T2 * of water and fat in vertebral bone marrow.
Le Ster C; Gambarota G; Lasbleiz J; Guillin R; Decaux O; Saint-Jalmes H
J Magn Reson Imaging; 2016 Sep; 44(3):549-55. PubMed ID: 26918280
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow involvement in lymphoma: the importance of marrow magnetic resonance imaging.
Takagi S; Tsunoda S; Tanaka O
Leuk Lymphoma; 1998 May; 29(5-6):515-22. PubMed ID: 9643565
[TBL] [Abstract][Full Text] [Related]
25. Quantification of fat deposition in bone marrow in the lumbar vertebra by proton MRS and in-phase and out-of-phase MRI for the diagnosis of osteoporosis.
Zhang L; Li S; Hao S; Yuan Z
J Xray Sci Technol; 2016; 24(2):257-66. PubMed ID: 27002905
[TBL] [Abstract][Full Text] [Related]
26. T2 relaxation times of irradiated vertebral bone marrow in patients with seminoma.
Argiris A; Maris T; Vlahos L
Magn Reson Imaging; 1997; 15(3):335-40. PubMed ID: 9201681
[TBL] [Abstract][Full Text] [Related]
27. Estimation of bone marrow cellularity by means of vertebral magnetic resonance.
Rozman M; Mercader JM; Aguilar JL; Montserrat E; Rozman C
Haematologica; 1997; 82(2):166-70. PubMed ID: 9175320
[TBL] [Abstract][Full Text] [Related]
28. A fast method for the quantification of fat fraction and relaxation times: Comparison of five sites of bone marrow.
Le Ster C; Lasbleiz J; Kannengiesser S; Guillin R; Gambarota G; Saint-Jalmes H
Magn Reson Imaging; 2017 Jun; 39():157-161. PubMed ID: 28263827
[TBL] [Abstract][Full Text] [Related]
29. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow disorders: characterization with quantitative MR imaging.
Smith SR; Williams CE; Davies JM; Edwards RH
Radiology; 1989 Sep; 172(3):805-10. PubMed ID: 2772192
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging for evaluation of childhood aplastic anemia.
Kanwar VS; Wang WC; Winer-Muram HT; Kauffman WM; Gronemeyer SA; Head DR
J Pediatr Hematol Oncol; 1995 Nov; 17(4):284-9. PubMed ID: 7583382
[TBL] [Abstract][Full Text] [Related]
32. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging.
Sanal SM; Flickinger FW; Caudell MJ; Sherry RM
J Clin Oncol; 1994 Jul; 12(7):1415-21. PubMed ID: 8021732
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.
Widding A; Smolorz J; Franke M; Linden A; Diehl V; Schicha H
Eur J Nucl Med; 1989; 15(5):230-8. PubMed ID: 2503382
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of bone marrow cellularity by magnetic resonance imaging in workers with long-term exposure to solvents.
Cheong HK; Choi DS; Park KU; Kim JR; Ha KI; Yun HJ; Yang SO; Kim Y
Ind Health; 2004 Apr; 42(2):179-88. PubMed ID: 15128167
[TBL] [Abstract][Full Text] [Related]
35. [Changes of bone marrow MRI pattern in aplastic anemia before and after bone marrow transplantation].
Masumoto A; Yonekura S; Ogawa Y; Fukuda R; Fujiwara H; Watanabe S; Satoh H; Kawada H; Umeda Y; Mishima K
Rinsho Ketsueki; 1993 Nov; 34(11):1494-6. PubMed ID: 8254913
[TBL] [Abstract][Full Text] [Related]
36. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
Moulin-Romsee G; Hindié E; Cuenca X; Brice P; Decaudin D; Bénamor M; Brière J; Anitei M; Filmont JE; Sibon D; de Kerviler E; Moretti JL
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1095-105. PubMed ID: 20204358
[TBL] [Abstract][Full Text] [Related]
37. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
[TBL] [Abstract][Full Text] [Related]
38. The relation of bone marrow scintigraphy and unilateral bone marrow biopsy in malignant lymphoma.
Esmaili J; Safaee SR; Sharifian R; Shoeybi S; Gholamrezanezhad A
Hell J Nucl Med; 2005; 8(2):125-8. PubMed ID: 16142255
[TBL] [Abstract][Full Text] [Related]
39. Applicability of 3T body MRI in assessment of nonfocal bone marrow involvement of hematopoietic neoplasia in dogs.
Feeney DA; Sharkey LC; Steward SM; Bahr KL; Henson MS; Ito D; O'Brien TD; Jessen CR; Husbands BD; Borgatti A; Modiano J
J Vet Intern Med; 2013; 27(5):1165-71. PubMed ID: 23888934
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies.
Akman B; Ata Korkmaz HA; Sarı A
Turk J Med Sci; 2019 Apr; 49(2):644-652. PubMed ID: 30889945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
